134 related articles for article (PubMed ID: 31188873)
1. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R
PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873
[TBL] [Abstract][Full Text] [Related]
2. PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.
Shah N; Wang J; Selich-Anderson J; Graham G; Siddiqui H; Li X; Khan J; Toretsky J
Clin Cancer Res; 2014 Aug; 20(16):4400-12. PubMed ID: 24947929
[TBL] [Abstract][Full Text] [Related]
3. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
4. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
5. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.
Kocak H; Ackermann S; Hero B; Kahlert Y; Oberthuer A; Juraeva D; Roels F; Theissen J; Westermann F; Deubzer H; Ehemann V; Brors B; Odenthal M; Berthold F; Fischer M
Cell Death Dis; 2013 Apr; 4(4):e586. PubMed ID: 23579273
[TBL] [Abstract][Full Text] [Related]
6. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
Reynolds CP
Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy.
Veselska R; Jezova M; Kyr M; Mazanek P; Chlapek P; Dobrotkova V; Sterba J
Front Oncol; 2019; 9():1221. PubMed ID: 31803613
[TBL] [Abstract][Full Text] [Related]
8. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
9. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
[TBL] [Abstract][Full Text] [Related]
10. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of RARgamma increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide.
Goranov BB; Campbell Hewson QD; Pearson AD; Redfern CP
Cell Death Differ; 2006 Apr; 13(4):676-9. PubMed ID: 16341128
[No Abstract] [Full Text] [Related]
12. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastoma.
Norris RE; Nguyen VT; Adamson PC
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e23-7. PubMed ID: 23669732
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
15. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate.
Neumann I; Foell JL; Bremer M; Volkmer I; Korholz D; Burdach S; Staege MS
Pediatr Blood Cancer; 2010 Sep; 55(3):464-70. PubMed ID: 20658618
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
18. Autophagy is associated with chemoresistance in neuroblastoma.
Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
20. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
